The prevalence of human papillomavirus in ovarian cancer : A systematic review

International Journal of Gynecological Cancer

Volumn 23, Issue 3, 2013, Pages 437-441

  Rosa, Maria Inês ^a   Silva, Geraldo Doneda ^a   De Azedo Simões, Priscyla Waleska Targino ^a   Souza, Meriene Viquetti ^a   Panatto, Ana Paula Ronzani ^a   Simon, Carla Sasso ^a   Madeira, Kristian ^a   Medeiros, Lidia Rossi ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

HPV; Meta analyses; Ovarian cancer; Prevalence; Systematic review

Indexed keywords

VIRUS DNA;

IN SITU HYBRIDIZATION; OVARY CANCER; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SOUTHERN BLOTTING; WART VIRUS;

BRAZIL; FEMALE; HUMANS; OVARIAN NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; TUMOR VIRUS INFECTIONS;

EID: 84876217173     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318280f3e0     Document Type: Review

References (30)

1. Colombo N, Peiretti M, Parma G, et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21:S23-S30.
2. Boyle P, Ferlay J. Cancer incidence and mortality in Europe. Ann Oncol. 2004;16:481-488.
3. Russell W. Adenovirus gene therapy for ovarian cancer. J Natl Cancer Inst. 2002;94:706-707.
4. Munoz N, Bosch FX, de Sanjose S, et al. International Agency for Research on Cancer Multicenter cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New Engl J Med. 2003;348:518-527.
5. zur Hausen H. Condylomata acuminata and human genital cancer. Cancer Res. 1976;36:794.
6. Remmink AJ, Walboomers JM, Helmerhorst TJ, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months. Int J Cancer. 1995;61:306-311.
7. Mai KT, Yazdi HM, Bertrand MA, et al. Bilateral primary ovarian squamous cell carcinoma associated with human papilloma virus infection and vulvar and cervical intraepithelial neoplasia. A case report with review of the literature. Am J Surg Pathol. 1996;20:767-772.
8. Review Manager (RevMan) [computer program]. Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2008.
9. Anttila M, Syrjanen S, Ji H, et al. Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR. Gynecol Oncol. 1999;72:337-341.
10. Anwar K, Nakakuki K, Imai H, et al. Infection of human papillomavirus (HPV) and p53 over-expression in human female genital tract carcinoma. J Pak Med Assoc. 1996;46:220-224.
11. Atalay F, Taskiran C, Taner MZ, et al. Detection of human papillomavirus DNA and genotyping in patients with epithelial ovarian carcinoma. J Obstet Gynaecol Res. 2007;33:823-828.
12. Beckmann AM, Sherman KJ, Saran L, et al. Genital-type human papillomavirus infection is not associated with surface epithelial ovarian carcinoma. Gynecol Oncol. 1991;43:247-251.
13. Bilyk OO, Pande NT, Buchynska LG. Analysis of p53, p16 (INK4a), pRb and cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas. Exp Oncol. 2011;33:150-156.
14. Chen TR, Chan PJ, Seraj IM, et al. Absence of human papillomavirus E6-E7 transforming genes from HPV 16 and 18 in malignant ovarian carcinoma. Gynecol Oncol. 1999;72:180-182.
15. de Villiers EM, Schneider A, Gross G, et al. Analysis of benign and malignant urogenital tumors for human papillomavirus infection by labelling cellular DNA. Med Microbiol Immunol. 1986;174:281-286.
16. Giordano G, D'Adda T, Gnetti L, et al. Role of human papillomavirus in the development of epithelial ovarian neoplasms in Italian women. J Obstet Gynaecol Res. 2008;34:210-217.
17. Hisada M, van den Berg BJ, Strickler HD, et al. Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States). Cancer Causes Control. 2001;12:335-341.
18. Idahl A, Lundin E, Elgh F, et al. Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions. Am J Obstet Gynecol. 2010;202:71.e1-71.e6.
19. Ip SM, Wong LC, Xu CM, et al. Detection of human papillomavirus DNA in malignant lesions from Chinese women with carcinomas of the upper genital tract. Gynecol Oncol. 2002;87:104-111.
20. Kuscu E, Ozdemir BH, Erkanli S, et al. HPVand p53 expression in epithelial ovarian carcinoma. Eur J Gynaecol Oncol. 2005;26:642-645.
21. Lai CH, Hsueh S, Lin CY, et al. Human papillomavirus in benign and malignant ovarian and endometrial tissues. Int J Gynecol Pathol. 1992;11:210-215.
22. Lai CH, Wang CY, Lin CY, et al. Detection of human papillomavirus RNA in ovarian and endometrial carcinomas by reverse transcription/polymerase chain reaction. Gynecol Obstet Invest. 1994;38:276-280.
23. Leake JF, Woodruff JD, Searle C, et al. Human papillomavirus and epithelial ovarian neoplasia. Gynecol Oncol. 1989;34:268-273.
24. Li T, Lu ZM, Guo M, et al. P53 codon 72 polymorphism (C/G) and the risk of human papillomavirusYassociated carcinomas in China. Cancer. 2002;95:2571-2576.
25. McLellan R, Buscema J, Guerrero E, et al. Investigation of ovarian neoplasia of low malignant potential for human papillomavirus. Gynecol Oncol. 1990;38:383-385.
26. Quirk JT, Kupinski JM, Di Cioccio RA. Analysis of ovarian tumors for the presence of human papillomavirus DNA. J Obstet Gynaecol Res. 2006;32:202-205.
27. Runnebaum IB, Maier S, Tong XW, Rosenthal HE, Mobus VJ, et al. Human papillomavirus integration is not associated with advanced epithelial ovarian cancer in German patients. Cancer Epidemiol Biomarkers Prev. 1995;4:573-575.
28. Shanmughapriya S, Senthilkumar G, Vinodhini K, et al. Viral and bacterial aetiologies of epithelial ovarian cancer. Eur J Clin Microbiol Infect Dis. 2012;31:2311-2317.
29. Trottier AM, Provencher D, Mes-Masson AM, et al. Absence of human papillomavirus sequences in ovarian pathologies. J Clin Microbiol. 1995;33:1011-1013.
30. Zimna K, Poreba E, Kedzia W, et al. Human papillomavirus (HPV) in upper genital tract carcinomas of women. Eur J Gynaecol Oncol. 1997;18:415-417.